- ►upenn.edu [PDF] GF Longstreth, WG Thompson, WD Chey, LA … - Gastroenterology, 2006 - Elsevier Employing a consensus approach, our working team critically considered the
available evidence and multinational expert criticism, revised the Rome II
diagnostic criteria for the functional bowel disorders, and updated ... Cited by 583 - Related articles - All 30 versions
LO'Mahony, J McCarthy, P Kelly, G Hurley, F … - Gastroenterology, 2005 - Elsevier Background & Aims: The aim of this study was to compare the response of symptoms
and cytokine ratios in irritable bowel syndrome (IBS) with ingestion of
probiotic preparations containing a lactobacillus or bifidobacterium ... Cited by 359 - Related articles - All 14 versions
- ►labdominguez.com.ar [PDF] T Poynard, C Regimbeau, Y Benhamou - Alimentary Pharmacology &# 38; Therapeutics, 2001 - ingentaconnect.com From this review it was concluded that, contrary to what had been previously
stated, ®ve drugs had proved their clinical ef®cacy without signi®cant
adverse reac- tions: cimetropium bromide, mebeverine, otilium bro- mide, ... Cited by 321 - Related articles - BL Direct - All 8 versions
M LEFKOWITZ - Aliment Pharmacol Ther, 2002 - misc.medscape.com Background: Irritable bowel syndrome is a common functional gastrointestinal
disorder which affects up to 20% of the population, with a predominance in
females. Aim: To evaluate the efficacy and safety of tegaserod in female ... Cited by 250 - Related articles - View as HTML - BL Direct - All 8 versions
- ►ucsf.edu [PDF] NJ Talley, R Spiller - The Lancet, 2002 - Elsevier Irritable bowel syndrome affects 10% of adults with an unexplained female
predominance. Although only a few people see their family doctor, the disease
causes reduced quality of life and represents a multi-billion pound ... Cited by 169 - Related articles - All 10 versions
F Cremonini, S Delgado-Aros, M Camilleri - Neurogastroenterology and Motility, 2003 - interscience.wiley.com Abstract The 5HT 3 receptor antagonist alosetron has been tested in several
trials on irritable bowel syndrome (IBS) patients. The aim of the present
meta-analysis was to determine its effect on adequate relief of pain or ... Cited by 145 - Related articles - BL Direct - All 3 versions
BJ Horwitz, RS Fisher - The New England journal of medicine, 2001 - nejm.highwire.org The irritable bowel syndrome is defined on the basis of the recently modified
Rome criteria as the presence for at least 12 weeks (not necessarily
consecutive) in the preceding 12 months of abdominal discomfort or pain ... Cited by 140 - Related articles - BL Direct - All 7 versions
NJ Talley - The Lancet, 2001 - Elsevier Irritable bowel syndrome (IBS) is common and can be disabling. Several drugs
that modulate serotonin (5HT) and other neurotransmitters in the gut
(neuroenteric modulators) have either become available or are in ... Cited by 140 - Related articles - BL Direct - All 6 versions
K Kroenke - International Journal of Methods in Psychiatric …, 2003 - interscience.wiley.com Somatic symptoms are the leading cause of outpatient medical visits and also the
predominant reason why patients with common mental disorders such as depression
and anxiety initially present in primary care. At least 33% of somatic ... Cited by 132 - Related articles - BL Direct - All 3 versions
G Tabas, M Beaves, J Wang, P Friday, H … - American Journal of Gastroenterology, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 113 - Related articles - BL Direct - All 6 versions
